| Literature DB >> 20689805 |
Luke C Mullany1, Thomas J Lee, Lin Yone, Catherine I Lee, Katherine C Teela, Palae Paw, Eh Kalu Shwe Oo, Cynthia Maung, Heather Kuiper, Nicole F Masenior, Chris Beyrer.
Abstract
BACKGROUND: Access to essential maternal and reproductive health care is poor throughout Burma, but is particularly lacking among internally displaced communities in the eastern border regions. In such settings, innovative strategies for accessing vulnerable populations and delivering basic public health interventions are urgently needed.Entities:
Mesh:
Year: 2010 PMID: 20689805 PMCID: PMC2914639 DOI: 10.1371/journal.pmed.1000317
Source DB: PubMed Journal: PLoS Med ISSN: 1549-1277 Impact factor: 11.069
Figure 1Map of Eastern Burma showing the MOM Project Communities.
Map was previously published in Mullany LC, et al. [11].
Survey sampling frame, coverage and response rate, and household size.
| Sample Characteristic | Karen | Karenni | Shan | Mon | Overall |
|
| 44,700 | 7,257 | 4,959 | 4,228 | 61,114 |
|
| 8,953 | 1,453 | 992 | 845 | 12,223 |
|
| 160 | 40 | N/A | N/A | 200 |
| Clusters reached | 138 (86.3%) | 37 (92.5%) | N/A | N/A | 175 (87.5%) |
|
| 1,600 | 400 | 400 | 400 | 2,800 |
| Surveys conducted | 1,380 (86.3%) | 367 (91.8%) | 337 (100.0%) | 400 (100.0%) | 2,484 (88.7%) |
| Agreed to participate | 1,339 (97.0%) | 367 (100.0%) | 337 (100.0%) | 399 (99.8%) | 2,442 (98.3%) |
| Total sample within participating households | 7,568 | 1,412 | 1,497 | 1,975 | 12,452 |
| Mean household size (SD) | 5.7 (2.1) | 3.8 (1.9) | 4.4 (1.7) | 4.9 (1.9) | 5.1 (2.1) |
Represents participation rate among those approached.
N/A, not available.
Comparison in demographic and socioeconomic characteristics between baseline (2006) and endline (2008) survey participants.
| Indicator | Baseline ( | Endline ( |
| Mean household size | 5.4 (2.1) | 5.1 (2.1) |
| Proportion Karen | 59.8% | 54.5% |
| Proportion Buddhist | 50.5% | 47.5% |
| Age of respondent (y) | 30.6 (7.5) | 30.5 (7.5) |
| Educational level (y) | 2.0 (2.8) | 2.6 (3.2) |
| Literate (reading and writing) | 52.5% | 51.8% |
| Married | 95.6% | 95.4% |
| Age at marriage (y) | 20.8 (5.0) | 20.6 (4.0) |
| Ever pregnant | 95.1% | 91.7% |
| Age at first pregnancy (y) | 20.8 (3.8) | 21.1 (3.7) |
| Number of times pregnant | 3.9 (2.6) | 3.4 (2.4) |
| Number of live births | 3.8 (2.3) | 3.5 (2.1) |
| Time since last pregnancy (y) | 2.5 (2.9) | 2.6 (3.0) |
Continuous indicators are shown as mean (standard deviation), while binary variables are given in terms of percentage.
The proportion Karen is a function of the sampling strategy and the response rate. In the 2008 endline survey, an entire Karen site was not accessed because of escalating conflict.
Changes in coverage of antenatal and postnatal interventions.
| Service Provided | Baseline ( | Endline ( | PRR (95% CI) |
|
| |||
| ≥1 ANC visits | 39.3% | 71.8% |
|
| ≥4 ANC visits | 16.7% | 34.4% |
|
|
| |||
| Blood pressure measured | 43.1% | 72.9% |
|
| Urine tested | 15.7% | 42.4% |
|
| Malaria test done | 21.9% | 55.5% |
|
| Positive rate | 36.7% | 11.8% |
|
| Tetanus toxoid | |||
| ≥1 dose | 22.4% | 15.6% | 0.69 (0.47–1.03) |
| ≥2 doses | 14.3% | 6.5% | 0.46 (0.20–1.03) |
| 90 d Fe/Folic Acid | 11.8% | 41.3% |
|
| Deworming treatment | 4.1% | 58.2% |
|
| Presumptive antimalarial provided | 9.8% | 12.5% | 1.27 (0.93–1.75) |
| Used insecticide treated net | 21.6% | 59.3% |
|
|
| |||
| PNC visit within 7 d | 33.7% | 69.8% |
|
| Skin-to-skin care given | 10.1% | 27.2% |
|
| Maternal post partum Vitamin A | 12.3% | 63.4% |
|
| Breastfeeding initiated within 24 h | 93.7% | 95.8% | 1.02 (0.99–1.05) |
Statistically significant comparisons are shown in bold.
Impact of program on family planning use and unmet need.
| Indicator/Method | Baseline | Endline | PRR (95% CI) | ||
|
| Percent |
| Percent | ||
| Do not want more children | 1,136 | 42.0 | 950 | 41.6 | 0.99 (0.91–1.07) |
| Doing anything to delay pregnancy | 725 | 25.3 | 1,110 | 46.7 |
|
| Using a modern method | 685 | 23.9 | 1,070 | 45.0 |
|
| Oral contraceptives | 149 | 5.2 | 388 | 16.3 |
|
| Depo-provera | 531 | 18.6 | 682 | 28.7 |
|
| Intra-uterine device | 6 | 0.2 | 30 | 1.3 |
|
| Norplant | 4 | 0.1 | 1 | 0.0 | 0.30 (0.31–2.90) |
| Condoms | 40 | 1.4 | 150 | 6.3 |
|
| Sterilization | 25 | 0.9 | 17 | 0.7 | 0.82 (0.42–1.59) |
| Unmet Need for Contraception2 | 1,764 | 61.7 | 963 | 40.5 |
|
Baseline, n = 2,702; Endline, n = 2,283.
Baseline, n = 2,861; Endline, n = 2,377.
Statistically significant comparisons are shown in bold.
Comparison of changes in key outcomes by region.
| Outcomes | Karen | Karenni | Shan | Mon | ||||
| Percent | PRR | Percent | PRR | Percent | PRR | Percent | PRR | |
|
| ||||||||
| ≥4 ANC visits | 17.3 | 2.38 (1.50–1.75) | 17.3 | 3.33 (1.38–8.02) | 82.4 | 1.86 (1.43–2.31) | 81.2 | 1.68 (1.32–2.14) |
| Blood pressure measured | 66.7 | 2.09 (1.79–2.44) | 85.6 | 1.63 (1.37–1.93) | 83.7 | 1.34 (1.05–1.71) | 80.9 | 1.18 (0.97–1.44) |
| Urine tested | 34.3 | 4.56 (3.24–6.42) | 70.7 | 5.93 (3.81–9.22) | 78.7 | 2.47 (1.68–3.63) | 27.4 | 0.62 (0.37–1.04) |
| Malaria test done | 48.5 | 3.15 (2.48–4.01) | 79.1 | 3.35 (2.38–4.70) | 77.9 | 3.78 (2.29–6.26) | 48.8 | 0.95 (0.51–1.79) |
| 90 d Fe/Folic Acid | 27.8 | 4.55 (3.04–6.80) | 68.3 | 14.8 (5.67–38.7) | 55.6 | 1.24 (0.63–2.44) | 68.0 | 3.47 (1.83–6.57) |
| Deworming treatment | 55.1 | 50.5 (30.2–84.6) | 67.3 | 7.86 (4.09–15.1) | 64.3 | 8.36 (5.34–13.1) | 58.9 | 5.79 (3.92–8.54) |
| Used insecticide treated net | 45.7 | 2.76 (2.11–3.60) | 76.9 | 5.24 (3.52–7.80) | 72.1 | 2.30 (0.49–10.7) | 93.9 | 2.12 (1.73–2.63) |
| PNC visit within 7 d | 63.8 | 2.33 (1.89–2.87) | 77.8 | 3.26 (2.46–4.31) | 74.6 | 1.18 (1.03–1.35) | 91.1 | 1.85 (1.43–2.39) |
| EmNOC-trained attendant | 41.8 | 22.4 (14.5–34.5) | 85.2 | 16.7 (9.84–28.4) | 76.2 | 5.59 (3.23–9.67) | 44.5 | 3.39 (1.84–6.27) |
|
| ||||||||
| Delaying pregnancy | 33.9 | 3.73 (2.81–4.95) | 38.9 | 2.60 (1.74–3.89) | 68.1 | 1.10 (0.85–1.42) | 74.2 | 0.91 (0.80–1.03) |
| Using a modern method | 33.6 | 3.98 (2.99–5.31) | 36.1 | 2.56 (1.67–3.93) | 61.7 | 1.11 (0.94–1.31) | 74.2 | 0.91 (0.79–1.05) |
| Oral contraceptives | 16.9 | 5.05 (3.33–7.66) | 13.0 | 1.70 (0.82–3.50) | 8.5 | 0.88 (0.14–5.62) | 17.8 | 2.22 (1.15–4.26) |
| Depo-provera | 14.8 | 3.64 (2.46–5.41) | 19.7 | 1.90 (1.13–3.18) | 49.7 | 1.15 (0.89–1.48) | 65.7 | 0.87 (0.78–0.98) |
| Condoms | 8.9 | 24.4 (8.81–67.7) | 8.2 | 2.06 (0.83–5.12) | 6.4 | 2.64 (1.32–5.27) | 0.0 | N/A |
| Unmet Need | 50.8 | 0.67 (0.60–0.75) | 38.5 | 0.51 (0.42–0.62) | 23.4 | 0.66 (0.39–1.11) | 21.6 | 1.29 (0.81–2.05) |
Perecentage reported at endline survey.
Relative change from baseline.
N/A, not available.